0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

a prescription for infringement? Actavis and Warner-Lambert - intention, or foreseeability?

26 October 2016

The Court of Appeal has handed down its judgment on the long-running Pregabalin saga. The patent was found invalid, so the reasoning below is non-binding, but adds clarity to when a claim in a patent for an alternative use of a medicine (a.k.a. 'Swiss-Form Claims') is infringed by a product which is labelled for use for a different purpose to that in the patent.

Previously, to infringe, the company selling the non-patented product had to “foresee that the product would be intentionally administered [by a doctor or pharmacist] for the use which was patented”. Floyd LJ has now clarified that the test is whether the manufacturer can “foresee that there will be intentional use” which matches the patented use.

Manufacturers selling an 'alternative use' product will not be able to avoid liability by simply having the proposed use on the label (and not the patented use). To negate the 'foreseeability' of intentional use for the patented purpose, additional steps such as notifying those prescribing the product that it must not be prescribed for the patented purpose, or applying warnings to this effect should be considered.

related opinions

Multi Skilled Visit: what is the impact of it being a right under the new Electronic Communications Code?

A Multi Skilled Visit (MSV) is when a survey is carried out on behalf of operators for the purpose of seeing whether a new site is suitable for the installation and operation of electronic communications equipment.

View blog

Deadline for registration for all operators and pilots of drones – midnight today!

Mandatory registration under the Drone Safe Drone and Model Aircraft Registration and Education Service starts at 00.00 on 30 November 2019.

View blog

Equal pay and the material factor defence

Equal pay claims, once the arena for public sector organisations only, have been spreading into the private sector over the last few years.

View blog

Supreme Court awards compensation to a Professor for an invention created during his employment

A recent decision by the Supreme Court in Shanks v Unilever PLC has supported the right for employees to receive compensation for patented inventions if the invention is of ‘outstanding benefit’.

View blog

mailing list sign up

Select which mailings you would like to receive from us.

Sign up